Baxter International Inc. (NYSE:BAX - Get Free Report) announced a quarterly dividend on Wednesday, April 29th. Investors of record on Friday, May 29th will be given a dividend of 0.01 per share by the medical instruments supplier on Wednesday, July 1st. This represents a c) annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, May 29th.
Baxter International has decreased its dividend by an average of 0.1%per year over the last three years. Baxter International has a payout ratio of 1.5% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Baxter International to earn $2.03 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.0%.
Baxter International Price Performance
NYSE:BAX traded down $0.08 during trading hours on Friday, hitting $17.50. The company's stock had a trading volume of 5,061,300 shares, compared to its average volume of 9,474,535. The stock has a fifty day simple moving average of $17.92 and a 200-day simple moving average of $19.18. The company has a market capitalization of $9.03 billion, a P/E ratio of -9.45, a PEG ratio of 1.20 and a beta of 0.62. The company has a debt-to-equity ratio of 1.55, a current ratio of 2.31 and a quick ratio of 1.56. Baxter International has a twelve month low of $15.73 and a twelve month high of $32.68.
Baxter International (NYSE:BAX - Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. The business had revenue of $2.70 billion for the quarter, compared to analyst estimates of $2.62 billion. Baxter International had a positive return on equity of 16.95% and a negative net margin of 8.51%.Baxter International's revenue was up 2.9% compared to the same quarter last year. During the same period last year, the firm posted $0.62 earnings per share. On average, analysts anticipate that Baxter International will post 1.91 EPS for the current fiscal year.
About Baxter International
(
Get Free Report)
Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company's primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter's offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.
In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Baxter International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Baxter International wasn't on the list.
While Baxter International currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.